Albemarle Q3 net sales beat on Energy Storage pricing strength

By Reuters News


Overview

  • US lithium and bromine supplier's Q3 net sales rose 19% yr/yr, beating analyst expectations

  • Adjusted EPS for Q3 beat analyst expectations

  • Q3 adjusted EBITDA slightly beat analyst estimates


Outlook

  • Albemarle raises 2026 Specialties adj EBITDA outlook to $350-$375 mln from $275-$325 mln

  • Company lowers 2026 capital expenditure forecast to $300-$350 mln from about $500 mln

  • Q4 2026 net sales and adj EBITDA expected to fall sequentially on lower market pricing


Result Drivers

  • HIGHER PRICING - Co said Q3 sales growth was primarily driven by higher prices in Energy Storage and Specialties, as well as volume growth in Specialties

  • COST AND PRODUCTIVITY IMPROVEMENTS - Co said ongoing cost and productivity improvements contributed to higher adjusted EBITDA

  • LITHIUM PRICING - Improved lithium pricing was a key driver of Energy Storage segment profitability, partly offset by higher input costs


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Net sales

Beat

$1.55 bln

$1.52 bln (12 Analysts)

Q3 Adjusted EPS

Beat

$2.58

$2.54 (15 Analysts)

Q3 EPS

$2.15

Q3 Adjusted EBITDA

Slight Beat*

$645.50 mln

$639.76 mln (13 Analysts)

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy", 7 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the specialty chemicals peer group is "buy"

  • Wall Street's median 12-month price target for Albemarle Corp is $155.00, about 71.9% above its November 3 closing price of $90.19

  • The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 10 three months ago


Reuters Recommended Reads

  • Nov 4 - AdvanSix Q3 sales rise on higher pricing

  • Nov 3 - Specialty chemicals supplier Innospec's Q3 revenue slightly misses estimates

  • Nov 3 - Rayonier Advanced Materials Q3 sales and EBITDA miss estimates on tariffs, impairments


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.